A PROSPECTIVE OPEN-LABEL CLINICAL TRIAL OF METHYLPHENIDATE PLUS A GWI-SPECIFIC NUTRIENT FORMULA IN PATIENTS WITH GULF WAR ILLNESS AND CONCENTRATION D
$610,441FY2014Department of the ArmyDOD
K-Pax Pharmaceuticals, Inc.
Investigators
View source on USAspending →A PROSPECTIVE OPEN-LABEL CLINICAL TRIAL OF METHYLPHENIDATE PLUS A GWI-SPECIFIC NUTRIENT FORMULA IN PATIENTS WITH GULF WAR ILLNESS AND CONCENTRATION D · GrantIndex